Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity

Autophagy

Volumn 10, Issue 11, 2014, Pages 2036-2052

  Cicchini, Michelle ^a,c   Chakrabarti, Rumela ^d   Kongara, Sameera ^a,c   Price, Sandy ^a,c   Nahar, Ritu ^c   Lozy, Fred ^a,c   Zhong, Hua ^b,c   Vazquez, Alexei ^a,c   Kang, Yibin ^a,d   Karantza, Vassiliki ^a,b,c,e  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d PRINCETON UNIVERSITY   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Basal like breast cancer; Beclin 1; Keratin 6; NFKB; Parity; TNBC; TNF11; TNFRSF11A; TNFSF11; TNR11; WNT1

Indexed keywords

BECLIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; OSTEOCLAST DIFFERENTIATION FACTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; REGULATOR PROTEIN; WNT1 PROTEIN; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; BECN1 PROTEIN, MOUSE; MEMBRANE PROTEIN; WNT1 PROTEIN, HUMAN; WNT1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; BREAST CARCINOGENESIS; CANCER INHIBITION; CANCER MODEL; CANCER PROGNOSIS; CANCER STEM CELL; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOSS; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PARITY; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TRIPLE NEGATIVE BREAST CANCER; ALLELE; ANIMAL; APOPTOSIS; BREAST TUMOR; CELL PROLIFERATION; CYTOLOGY; DNA MICROARRAY; EPITHELIUM CELL; EXPERIMENTAL MAMMARY NEOPLASM; HETEROZYGOTE; METABOLISM; NUDE MOUSE; STEM CELL;

MOUSE MAMMARY TUMOR VIRUS; MUS;

ALLELES; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BREAST NEOPLASMS; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROZYGOTE; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANE PROTEINS; MICE; MICE, NUDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STEM CELLS; TRIPLE NEGATIVE BREAST NEOPLASMS; WNT1 PROTEIN;

EID: 84919767331     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.34398     Document Type: Article

References (60)

1. Mizushima N, Levine B, Cuervo AM, Klionsky DJ Autophagy fights disease through cellular self-digestion. Nature 2008; 451:1069-75; http://dx.doi.org/10.1038/nature06639; PMID:18305538
2. Aita VM, Liang XH, Murty VV, Pincus DL, Yu W, Cayanis E, Kalachikov S., Gilliam TC, Levine B. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999; 59:59-65; PMID:10395800; http://dx.doi.org/10.1006/geno.1999.5851
3. Liang XH, Jackson S, Seaman M., Brown K, Kempkes B, Hibshoosh H., Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402:672-6; http://dx.doi.org/10.1038/45257; PMID:10604474
4. Qu X, Yu J, Bhagat G., Furuya N, Hibshoosh H, Troxel A., Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y., et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003; 112:1809-20; http://dx.doi.org/10.1172/JCI20039; PMID:14638851
5. Yue Z, Jin S, Yang C., Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 2003; 100:15077-82; http://dx.doi.org/10.1073/pnas.2436255100; PMID: 14657337
6. Karantza-Wadsworth V., Patel S, Kravchuk O., Chen G, Mathew R, Jin S., White E. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 2007; 21:1621-35; PMID: 17606641; http://dx.doi.org/10.1101/gad.1565707
7. Rosenfeldt MT, O'Prey J, Morton JP, Nixon C, MacKay G., Mrowinska A, Au A, Rai TS, Zheng L., Ridgway R, et al. p53 status determines the role of autophagy in pancreatic tumour development. Nature 2013; 504:296-300; http://dx.doi.org/10.1038/nature12865; PMID:24305049
8. Lozy F, Cai-McRae X, Teplova I., Price S, Reddy A, Bhanot G., Ganesan S, Vazquez A, Karantza V. ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 loss. Autophagy 2014; 10:662-76; PMID:24492513; http://dx.doi.org/10.4161/auto.27867
9. Wei Y, Zou Z, Becker N., Anderson M, Sumpter R, Xiao G., Kinch L, Koduru P, Christudass CS, Veltri RW, et al. EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance. Cell 2013; 154:1269-84; http://dx.doi.org/10.1016/j.cell.2013.08.015; PMID:24034250
10. Gong C, Bauvy C, Tonelli G., Yue W, Delomenie C, Nicolas V., Zhu Y, Domergue V, Marin-Esteban V, Tharinger H., et al. Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells. Oncogene 2013; 32:2261-72, 1-11; PMID:22733132; http://dx.doi.org/10.1038/onc.2012.252
11. Guo JY, Karsli-Uzunbas G, Mathew R., Aisner SC, Kamphorst JJ, Strohecker AM, Chen G, Price S., Lu W, Teng X, et al Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev 2013; 27:1447-61; http://dx.doi.org/10.1101/gad.219642.113; PMID: 23824538
12. Strohecker AM, Guo JY, Karsli-Uzunbas G, Price SM, Chen GJ, Mathew R, McMahon M, White E. Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discov 2013; 3:1272-85; PMID:23965987; http://dx.doi.org/10.1158/2159-8290.CD-13-0397
13. Huo Y, Cai H, Teplova I., Bowman-Colin C, Chen G, Price S., Barnard N, Ganesan S, Karantza V., White E, et al. Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer. Cancer Discov 2013; 3:894-907; http://dx.doi.org/10.1158/2159-8290.CD-13-0011; PMID:23650262
14. Wei H, Wei S, Gan B., Peng X, Zou W, Guan JL Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes Dev 2011; 25: 1510-27; http://dx.doi.org/10.1101/gad.2051011; PMID:21764854
15. Teplova I, Lozy F, Price S., Singh S, Barnard N, Cardiff RD, Birge RB, Karantza V. ATG proteins mediate efferocytosis and suppress inflammation in mammary involution. Autophagy 2013; 9:459-75; http://dx.doi.org/10.4161/auto.23164; PMID:23380905
16. Laddha SV, Ganesan S, Chan CS, White E. Mutational landscape of the essential autophagy gene BECN1 in human cancers. Mol Cancer Res 2014; 12:485-90; PMID:24478461; http://dx.doi.org/10.1158/1541-7786.MCR-13-0614
17. Kongara S, Kravchuk O, Teplova I., Lozy F, Schulte J, Moore D., Barnard N, Neumann CA, White E, Karantza V. Autophagy regulates keratin 8 homeostasis in mammary epithelial cells and in breast tumors. Mol Cancer Res 2010; 8:873-84; http://dx.doi.org/10.1158/1541-7786.MCR-09-0494; PMID:20530580
18. Li Y, Welm B, Podsypanina K., Huang S, Chamorro M, Zhang X., Rowlands T, Egeblad M, Cowin P., Werb Z, et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci U S A 2003; 100:15853-8; http://dx.doi.org/10.1073/pnas.2136825100; PMID:14668450
19. Bu W, Chen J, Morrison GD, Huang S., Creighton CJ, Huang J, Chamness GC, Hilsenbeck SG, Roop DR, Leavitt AD, et al Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer. Oncogene 2011; 30:4399-409; http://dx.doi.org/10.1038/onc.2011.147; PMID:21532625
20. Liu BY, McDermott SP, Khwaja SS, Alexander CM The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc Natl Acad Sci U S A 2004; 101:4158-63; http://dx.doi.org/10.1073/pnas.0400699101; PMID:15020770
21. Grimm SL, Bu W, Longley MA, Roop DR, Li Y, Rosen JM Keratin 6 is not essential for mammary gland development. Breast Cancer Res 2006; 8:R29; PMID:16790075; http://dx.doi.org/10.1186/bcr1504
22. Shackleton M, Vaillant F, Simpson KJ, Stingl J., Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE Generation of a functional mammary gland from a single stem cell. Nature 2006; 439:84-8; http://dx.doi.org/10.1038/nature04372; PMID:16397499
23. Stingl J, Eirew P, Ricketson I., Shackleton M, Vaillant F, Choi D., Li HI, Eaves CJ Purification and unique properties of mammary epithelial stem cells. Nature 2006; 439:993-7; http://dx.doi.org/10.1038/nature04496; PMID:16395311
24. Vaillant F, Asselin-Labat ML, Shackleton M., Forrest NC, Lindeman GJ, Visvader JE The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res 2008; 68:7711-7; http://dx.doi.org/10.1158/0008-5472.CAN-08-1949; PMID:18829523
25. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003; 17:1253-70; http://dx.doi.org/10.1101/gad.1061803; PMID:12756227
26. Komatsu M, Waguri S, Ueno T., Iwata J, Murata S, Tanida I., Ezaki J, Mizushima N, Ohsumi Y., Uchiyama Y, et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol 2005; 169:425-34; http://dx.doi.org/10.1083/jcb.200412022; PMID:15866887
27. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 2001; 29:418-25; http://dx.doi.org/10.1038/ng747; PMID:11694875
28. Joshi PA, Jackson HW, Beristain AG, Di Grappa MA, Mote PA, Clarke CL, Stingl J, Waterhouse PD, Khokha R. Progesterone induces adult mammary stem cell expansion. Nature 2010; 465:803-7; http://dx.doi.org/10.1038/nature09091; PMID:20445538
29. Gonzalez-Suarez E., Branstetter D, Armstrong A., Dinh H, Blumberg H, Dougall WC RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini. Mol Cell Biol 2007; 27:1442-54; http://dx.doi.org/10.1128/MCB.01298-06; PMID:17145767
30. Fernandez-Valdivia R., Mukherjee A, Ying Y., Li J, Paquet M, DeMayo FJ, Lydon JP The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse. Dev Biol 2009; 328:127-39; http://dx.doi.org/10.1016/j.ydbio.2009.01.019; PMID:19298785
31. Darnay BG, Ni J, Moore PA, Aggarwal BB Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif. J Biol Chem 1999; 274:7724-31; PMID: 10075662; http://dx.doi.org/10.1074/jbc.274.12.7724
32. Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B., Wu D, Simpson ER, Yasuda H, Smyth GK, Martin TJ, Lindeman GJ, et al Control of mammary stem cell function by steroid hormone signalling. Nature 2010; 465:798-802; http://dx.doi.org/10.1038/nature09027; PMID:20383121
33. Dougall WC. RANKL signaling in bone physiology and cancer. Curr Opin Support Palliat Care 2007; 1:317-22; http://dx.doi.org/10.1097/SPC.0b013e3282f335be; PMID:18685382
34. Gonzalez-Suarez E., Jacob AP, Jones J, Miller R., Roudier-Meyer MP, Erwert R, Pinkas J., Branstetter D, Dougall WC RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature 2010; 468:103-7; http://dx.doi.org/10.1038/nature09495; PMID:20881963
35. Lydon JP, DeMayo FJ, Conneely OM, O'Malley BW. Reproductive phenotpes of the progesterone receptor null mutant mouse. J Steroid Biochem Mol Biol 1996; 56:67-77; PMID:8603049; http://dx.doi.org/10.1016/0960-0760(95)00254-5
36. Takayanagi H, Sato K, Takaoka A., Taniguchi T. Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev 2005; 208:181-93; http://dx.doi.org/10.1111/j.0105-2896.2005.00337.x; PMID:16313349
37. Kongara S, Karantza V. The interplay between autophagy and ROS in tumorigenesis. Front Oncol 2012; 2:171; PMID:23181220
38. Davie SA, Maglione JE, Manner CK, Young D., Cardiff RD, MacLeod CL, Ellies LG Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice. Transgenic Res 2007; 16:193-201; http://dx.doi.org/10.1007/s11248-006-9056-9; PMID:17206489
39. Visvader JE. Cells of origin in cancer. Nature 2011; 469:314-22; http://dx.doi.org/10.1038/nature09781; PMID:21248838
40. Li Y, Hively WP, Varmus HE Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 2000; 19:1002-9; http://dx.doi.org/10.1038/sj.onc.1203273; PMID:10713683
41. Liu J, Xia H, Kim M., Xu L, Li Y, Zhang L., Cai Y, Norberg HV, Zhang T, Furuya T., et al. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell 2011; 147:223-34; http://dx.doi.org/10.1016/j.cell.2011.08.037; PMID:21962518
42. Hatzis C, Pusztai L, Valero V., Booser DJ, Esserman L, Lluch A, Vidaurre T., Holmes F, Souchon E, Wang H., et al. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 2011; 305:1873-81; http://dx.doi.org/10.1001/jama.2011.593; PMID:21558518
43. Sabatier R, Finetti P, Cervera N., Lambaudie E, Esterni B, Mamessier E., Tallet A, Chabannon C, Extra JM, Jacquemier J., et al. A gene expression signature identifies two prognostic subgroups of basal breast cancer. Breast Cancer Res Treat 2011; 126:407-20; http://dx.doi.org/10.1007/s10549-010-0897-9; PMID:20490655
44. Shravage BV, Hill JH, Powers CM, Wu L., Baehrecke EH Atg6 is required for multiple vesicle trafficking pathways and hematopoiesis in Drosophila. Development 2013; 140:1321-9; http://dx.doi.org/10.1242/dev.089490; PMID:23406899
45. Wang C, Liang CC, Bian ZC, Zhu Y., Guan JL FIP200 is required for maintenance and differentiation of postnatal neural stem cells. Nat Neurosci 2013; 16:532-42; http://dx.doi.org/10.1038/nn.3365; PMID:23542691
46. Schramek D, Leibbrandt A, Sigl V., Kenner L, Pospisilik JA, Lee HJ, Hanada R., Joshi PA, Aliprantis A, Glimcher L, et al Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 2010; 468:98-102; http://dx.doi.org/10.1038/nature09387; PMID:20881962
47. Palafox M, Ferrer I, Pellegrini P., Vila S, Hernandez-Ortega S, Urruticoechea A, Climent F., Soler MT, Munoz P, Vinals F, et al RANK induces epithelialmesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. Cancer Res 2012; 72:2879-88; http://dx.doi.org/10.1158/0008-5472.CAN-12-0044; PMID:22496457
48. Kuhn MC, Willenberg HS, Schott M, Papewalis C., Stumpf U, Flohe S, Scherbaum WA, Schinner S. Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation. Mol Cell Endocrinol 2012; 349:180-8; http://dx.doi.org/10.1016/j.mce.2011.10.018; PMID:22040599
49. Bendre M, Gaddy D, Nicholas RW, Suva LJ Breast cancer metastasis to bone: it is not all about PTHrP. Clin Orthop Relat Res 2003; (Suppl):S39-45; http://dx.doi.org/10.1097/01.blo.0000093844.72468.f4; PMID:14600591
50. Takamura A, Komatsu M, Hara T., Sakamoto A, Kishi C, Waguri S., Eishi Y, Hino O, Tanaka K., Mizushima N. Autophagy-deficient mice develop multiple liver tumors. Genes Dev 2011; 25:795-800; http://dx.doi.org/10.1101/gad.2016211; PMID:21498569
51. Marino G, Salvador-Montoliu N, Fueyo A., Knecht E, Mizushima N, Lopez-Otin C. Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. J Biol Chem 2007; 282:18573-83; PMID:17442669; http://dx.doi.org/10.1074/jbc.M701194200
52. Cook KL, Shajahan AN, Clarke R. Autophagy and endocrine resistance in breast cancer. Expert Rev Anticancer Ther 2011; 11:1283-94; http://dx.doi.org/10.1586/era.11.111; PMID:21916582
53. Alexander CM, Goel S, Fakhraldeen SA, Kim S. Wnt signaling in mammary glands: plastic cell fates and combinatorial signaling. Cold Spring Harb Perspect Biol 2012; 4: http://dx.doi.org/10.1101/cshperspect.a008037; PMID:22661590
54. Bertrand FE, Angus CW, Partis WJ, Sigounas G. Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch. Cell Cycle 2012; 11:4344-51; http://dx.doi.org/10.4161/cc.22134; PMID:23032367
55. Howe LR, Brown AM Wnt signaling and breast cancer. Cancer Biol Ther 2004; 3:36-41; PMID:14739782; http://dx.doi.org/10.4161/cbt.3.1.561
56. Geyer FC, Lacroix-Triki M, Savage K., Arnedos M, Lambros MB, MacKay A, Natrajan R., Reis-Filho JS. β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation. Mod Pathol 2011; 24:209-31; http://dx.doi.org/10.1038/modpathol.2010.205; PMID:21076461
57. Alanazi MS, Parine NR, Shaik JP, Alabdulkarim HA, Ajaj SA, Khan Z. Association of single nucleotide polymorphisms in Wnt signaling pathway genes with breast cancer in Saudi patients. PLoS One 2013; 8:e59555; http://dx.doi.org/10.1371/journal.pone.0059555; PMID:23516639
58. Benhaj K, Akcali KC, Ozturk M. Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol Rep 2006; 15:701-7; PMID:16465433
59. Goessl C, Katz L, Dougall WC, Kostenuik PJ, Zoog HB, Braun A, Dansey R., Wagman RB The development of denosumab for the treatment of diseases of bone loss and cancer-induced bone destruction. Ann N Y Acad Sci 2012; 1263:29-40; http://dx.doi.org/10.1111/j.1749-6632.2012.06674.x; PMID:22831177
60. Liu X, Holstege H, van der Gulden H, Treur-Mulder M, Zevenhoven J, Velds A, Kerkhoven RM, van Vliet MH, Wessels LF, Peterse JL, et al. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc Natl Acad Sci U S A 2007; 104:12111-6; http://dx.doi.org/10.1073/pnas.0702969104; PMID:17626182